A detailed history of Camden Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Camden Capital, LLC holds 3,076 shares of BSX stock, worth $276,840. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,076
Previous 3,001 2.5%
Holding current value
$276,840
Previous $231,000 11.26%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.96 - $84.0 $5,471 - $6,300
75 Added 2.5%
3,076 $257,000
Q2 2024

Aug 06, 2024

SELL
$67.33 - $77.71 $38,580 - $44,527
-573 Reduced 16.03%
3,001 $231,000
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $115 - $137
2 Added 0.06%
3,574 $244,000
Q4 2023

Feb 05, 2024

BUY
$48.64 - $57.81 $173,742 - $206,497
3,572 New
3,572 $206,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.